Theyre delicate and typically require refrigeration or specific stabilization to be effective
The first case involves a 54-year-old man who, about one month after starting semaglutide, experienced a marked decline in energy, motivation, fatigue, difficulty concentrating, and mood disturbances
The UK, for example, spends around GBP7 million/US$8.8 million a year on this alone
Real World Impact: Current Use and Outcomes These medications are no longer niche, they're influencing population level trends: Rapid Growth in Use In the U.S., reported use of GLP-1 weight loss drugs has more than doubled in the past year, from about 5.8% of adults in early 2024 to over 12% in 2025 Women tend to use these medications at higher rates than men, with 15.2% vs
What is the Bridge program
Conclusions In summary, SGLT-2 inhibitors are superior in reducing cardiovascular death, hospitalization for HF, and renal events among the new antidiabetic drug classes